Its activity has been associated with the downregulation of oncoproteins such as Akt, epithelial growth factor receptor (EGFR), and Raf-1, and it has also demonstrated effectiveness in combination therapies, enhancing the effects of other cancer treatments such as BH3 mimetics and radiation therapy[95]. The gene discussed is RAF1; the disease is cancer.